Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Compugen Ltd (NQ: CGEN)
3.970 USD  +0.060 (+1.53%)
Official Closing Price  /  Updated: 4:00 PM EDT, Aug 21, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 126,100
Open 3.930
Bid (Size) 3.820 (1)
Ask (Size) 4.370 (2)
Prev. Close 3.910
Today's Range 3.876 - 4.030
52wk Range 2.000 - 4.310
Shares Outstanding 45,822,807
Dividend Yield N/A
Performance
YTD
+68.94%
+68.94%
1 Month
+18.86%
+18.86%
3 Month
+18.15%
+18.15%
6 Month
+12.78%
+12.78%
1 Year
+13.43%
+13.43%
Top News
More News
Compugen Reports Second Quarter 2019 Results
Compugen Ltd. (Nasdaq: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today reported financial results for the second quarter ended... Read More
from PR Newswire
Compugen Second Quarter 2019 Conference Call Scheduled for Monday, August 5, 2019 at 8:30 AM ET
Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, announced today that the Company will release its second quarter... Read More
from PR Newswire
More News
Read More
Compugen Expands Intellectual Property Portfolio for COM701 with New U.S. Patent Covering Combination Use with anti-PD-1 Antibody
from PR Newswire
Compugen Appoints Eran Perry to Its Board of Directors
from PR Newswire
Compugen Presents Update on COM701 Phase 1 Trial at the 2019 ASCO Annual Meeting
from PR Newswire
Compugen to Present at the Jefferies 2019 Healthcare Conference
from PR Newswire
Compugen Reports First Quarter 2019 Results
from PR Newswire
Compugen Doses First Patient in COM701/Opdivo® (Nivolumab) Combination Arm of Phase 1 Study in Patients With Advanced Solid Tumors
from PR Newswire
Compugen First Quarter 2019 Conference Call Scheduled for Monday, May 20, 2019 at 8:30 AM ET
from PR Newswire
Report: Exploring Fundamental Drivers Behind Masco, Ascena Retail Group, Minerva Neurosciences, Compugen, Mountain Province Diamonds, and Luna Innovations — New Horizons, Emerging Trends, and Upcoming
from GlobeNewswire News Releases
Compugen Ltd. (CGEN) Q2 2019 Earnings Call Transcript
category Market News , CGEN
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.